1. $Neon Therapeutics(NTGN)$ 是一家成立于2013年以生命医学界著名的哈佛和麻省理工共建的Broad 研究所的研究成果为基础研发药物的公司。
2. 处于1期临床的NEO-PV-01的试验有着很好的前景,部分临床数据会在今年10月举办的ESMO上公布。
3. 自体T细胞靶向肿瘤新生抗原疗法有着...查看全文
橫舟2018-10-04 02:46
$Neon Therapeutics, Inc.(NTGN)$ CAR-T 受制于tumor 已知特异抗原太少,CPB (checkpoint blockade)受制于体内识别tumor的T细胞太少,所以公司的技术路线是通过筛选特异抗原,扩增有效T细胞。查看全文
gray132018-10-02 00:22
$Neon Therapeutics, Inc.(NTGN)$ 更正一下 人家没加大嘛。。人家是得了诺贝尔奖 今天看到消息了 结果无视 损失了一个亿的感觉
Neon Therapeutics Congratulates Founder James P. Allison, Ph.D., for 2018 Nobel Prize in Physiology or Medicine查看全文
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000062 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000063 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000064 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000065 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000066 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000067 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000068 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000069 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000070 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000071 Size: 10 KB 网页链接